Abstract
In this issue of Blood, Goldsmith et al report that the use of posttransplantation cyclophosphamide (PTCy) doubled the risk of cytomegalovirus (CMV) i......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
